Comet Bio

Comet Bio

Private
London, OntarioHealthcare & Life Scienceshttps://comet-bio.com/

Last Round

Debt

Jul 3, 2023

Total Funding Raised

$76.78M

Momentum Score

25 /100

Company Overview

Comet Bio is a food technology company that produces healthy and sustainable ingredients by upcycling crop leftovers. The company's patented technology converts agricultural residues into products like Arrabina, a prebiotic dietary fiber, and Sweeterra, a line of sustainable, lower-sugar syrup blends. Arrabina is clinically proven to support gut health, help maintain healthy blood glucose levels, and support immunity. Comet Bio aims to address consumer demand for gut health, sugar reduction, and reduced food system waste. The company has a Canadian headquarters in London, Ontario, a U.S. headquarters in Schaumburg, Illinois, and a manufacturing facility in Kalundborg, Denmark.

Sector

Healthcare & Life Sciences

Verticals

Circular Economy, Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

upcycled ingredientsprebiotic fiberfood techupcycling technologysustainable ingredientsArabinoxylanfunctional ingredientsB2B ingredientsgut health ingredientsagricultural upcyclingplant-based ingredientssugar reductionbiorefinerycircular economyfood waste valorizationhydrothermal processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Comet Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Comet Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtJul 3, 2023
Series CJul 13, 2021
Series AJul 16, 2019
VC RoundFeb 28, 2017
GrantMar 7, 2016
VC Round
Feb 25, 2015

Key People

Founding team and executive leadership

Loula Merkel

Chief Business Officer, Chief Executive Officer, Vice President Of Business Development

Executive Team

Comet Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    Added Integrative, a health & wellness company, as a customer.

  • Nov 12, 2025

    Developing a protein drink in partnership with Puris.

Comet Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Comet Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Comet Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, Ontario
Employee Range19
Year Founded2009
Last FundingJul 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.